Business
BELLUS HEALTH REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2011
Jun. 8, 2011 (Canada NewsWire Group) -- Patient recruitment on-going for KIACTA ™...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n Jun. 8, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nPatient recruitment on-going for KIACTA™ Confirmatory Phase III Clinical Trial\n\n\nLAVAL, QC, June 8, 2011 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU)\n ("BELLUS Health" or the "Company") reported today its financial results\n for the first quarter ended March 31, 2011.\n\n\nThese financial results were prepared in accordance with International\n Financial Reporting Standards ("IFRS"), as issued by the International\n Accounting Standards Board. Comparative figures for 2010 that were\n previously reported in accordance with Canadian Generally Accepted\n Accounting Principles have been restated to conform to IFRS. For more\n information regarding the conversion to IFRS, please refer to note 14\n of the Company's Consolidated Financial Statements for the three-month\n period ended March 31, 2011. All currency figures reported in this\n press release, including comparative figures, are in Canadian dollars,\n unless otherwise specified.\n\n\n"During the first quarter, we continued to implement our business plan\n including the initiation of patient recruitment for the confirmatory\n phase III clinical trial for KIACTA™, our lead drug candidate." said\n Roberto Bellini, President and Chief Executive Officer of BELLUS\n Health. "We also concluded our corporate reorganization enabling us to\n significantly reduce our burn rate and extend our cash r...